ASMI welcomes Federal Government’s measures to cut red tape by accepting trusted international standards
15 October 2014 - The Australian Self Medication Industry (ASMI) welcomed the Federal Government's announcement that it will examine opportunities for greater acceptance of international standards and risk assessments.
ASMI Executive Director Dr Deon Schoombie, said: "While this announcement specifically mentions medical devices and industrial chemicals, ASMI argues that it should also include over-the-counter and complementary medicines.
"There is no compelling reason why the Therapeutic Goods Administration (TGA) should re-assess non-prescription medicines where they have already been assessed by comparable overseas regulators.
"Recognising regulatory approvals of trusted overseas regulators will reduce barriers and offer Australian consumers faster access to innovative healthcare products. It will enable manufacturers and marketers of therapeutic goods to be more responsive and cost-effective.
"ASMI looks forward to working with the TGA to identify opportunities for reforms and to implement them.
"This is a great opportunity to re-visit those areas where the
TGA is out of step with the rest of the world such as
down-scheduling of certain prescription medicines to
non-prescription, advertising of non-prescription medicines,
scheduling of combination products, and regulation of the lowest
risk complementary medicines," Dr Schoombie added.
About ASMI: The Australian Self-Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines. Its members make up 85 per cent of the $4bn self care market. Membership totals 60 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to promote better health through responsible self care. This means ensuring that safe and effective self care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective self-medication products as part of the broad national health strategy (www.asmi.com.au).
For more information or to arrange a media interview, please
PR Manager, Australian Self Medication Industry (ASMI)
M:0408 256 381 E: email@example.com